The results from these in vivo studies consistently showed increased tumor cell apoptosis and a notable decrease in tumor size, thereby providing a strong rationale for utilizing IL‐24 in combination with radiation therapy to improve cancer treatment outcomes. This evidence concerns the gene IL24 and neoplasm.